We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine f... Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of hepatitis B. Dynavax operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product. Show more
BEDFORD, Mass., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find...
Dynavax Reports Second Quarter 2024 Financial Results and Provides Business Updates PR Newswire EMERYVILLE, Calif., Aug. 6, 2024 Achieved record quarterly HEPLISAV-B® net product revenue of $70.2...
Dynavax to Report Second Quarter 2024 Financial Results and Host Conference Call on August 6, 2024 PR Newswire EMERYVILLE, Calif., July 23, 2024 EMERYVILLE, Calif., July 23, 2024 /PRNewswire/...
Dynavax Initiates Phase 1/2 Study of Novel Shingles Vaccine Program PR Newswire EMERYVILLE, Calif., June 27, 2024 EMERYVILLE, Calif., June 27, 2024 /PRNewswire/ -- Dynavax Technologies...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.09 | -0.803571428571 | 11.2 | 11.575 | 10.98 | 2156478 | 11.31202858 | CS |
4 | -0.25 | -2.20070422535 | 11.36 | 11.575 | 10.555 | 2125703 | 11.0974369 | CS |
12 | -0.06 | -0.53715308863 | 11.17 | 11.7 | 9.74 | 2081109 | 10.96032089 | CS |
26 | -1.15 | -9.38009787928 | 12.26 | 12.86 | 9.74 | 2119483 | 11.3169691 | CS |
52 | -2.51 | -18.4287812041 | 13.62 | 15.15 | 9.74 | 1962614 | 12.31066604 | CS |
156 | -8.095 | -42.1504816454 | 19.205 | 21.39 | 7.26 | 1975972 | 12.62743042 | CS |
260 | 6.51 | 141.52173913 | 4.6 | 21.39 | 1.8 | 2666708 | 10.16704318 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions